ELDN Annual Cash & Cash Equivalents
$4.61 M
-$51.80 M-91.82%
31 December 2023
Summary:
As of January 23, 2025, ELDN annual cash & cash equivalents is $4.61 million, with the most recent change of -$51.80 million (-91.82%) on December 31, 2023. During the last 3 years, it has fallen by -$109.58 million (-95.96%). ELDN annual cash & cash equivalents is now -95.96% below its all-time high of $114.19 million, reached on December 31, 2020.ELDN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN Quarterly Cash And Cash Equivalents
$6.75 M
-$19.29 M-74.07%
30 September 2024
Summary:
As of January 23, 2025, ELDN quarterly cash and cash equivalents is $6.75 million, with the most recent change of -$19.29 million (-74.07%) on September 30, 2024. Over the past year, it has increased by +$3.08 million (+84.10%). ELDN quarterly cash and cash equivalents is now -94.10% below its all-time high of $114.46 million, reached on September 30, 2020.ELDN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELDN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.8% | +84.1% |
| 3 y3 years | -96.0% | +84.1% |
| 5 y5 years | -64.5% | +84.1% |
ELDN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.6% | at low | -92.0% | +84.1% |
| 5 y | 5-year | -96.0% | at low | -94.1% | +84.1% |
| alltime | all time | -96.0% | +318.1% | -94.1% | +512.1% |
Eledon Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.75 M(-74.1%) |
| June 2024 | - | $26.04 M(+360.5%) |
| Mar 2024 | - | $5.66 M(+22.6%) |
| Dec 2023 | $4.61 M(-91.8%) | $4.61 M(+25.8%) |
| Sept 2023 | - | $3.67 M(-91.0%) |
| June 2023 | - | $40.95 M(-11.9%) |
| Mar 2023 | - | $46.48 M(-17.6%) |
| Dec 2022 | $56.41 M(-33.5%) | $56.41 M(-14.4%) |
| Sept 2022 | - | $65.89 M(-6.5%) |
| June 2022 | - | $70.46 M(-8.1%) |
| Mar 2022 | - | $76.68 M(-9.6%) |
| Dec 2021 | $84.83 M(-25.7%) | $84.83 M(-9.8%) |
| Sept 2021 | - | $94.04 M(-7.0%) |
| June 2021 | - | $101.13 M(-6.9%) |
| Mar 2021 | - | $108.58 M(-4.9%) |
| Dec 2020 | $114.19 M(+1199.0%) | $114.19 M(-0.2%) |
| Sept 2020 | - | $114.46 M(+1206.1%) |
| June 2020 | - | $8.76 M(-25.6%) |
| Mar 2020 | - | $11.79 M(+34.1%) |
| Dec 2019 | $8.79 M | $8.79 M(-18.7%) |
| Sept 2019 | - | $10.81 M(-21.1%) |
| June 2019 | - | $13.70 M(+51.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $9.06 M(-30.2%) |
| Dec 2018 | $12.97 M(-24.7%) | $12.97 M(-20.5%) |
| Sept 2018 | - | $16.32 M(-14.9%) |
| June 2018 | - | $19.19 M(-14.8%) |
| Mar 2018 | - | $22.52 M(+30.7%) |
| Dec 2017 | $17.23 M(+1462.4%) | $17.23 M(-9.7%) |
| Sept 2017 | - | $19.09 M(-15.1%) |
| June 2017 | - | $22.50 M(-7.8%) |
| Mar 2017 | - | $24.40 M(+2112.1%) |
| Dec 2016 | $1.10 M(-95.4%) | $1.10 M(-94.1%) |
| Sept 2016 | - | $18.63 M(+53.3%) |
| June 2016 | - | $12.16 M(-15.0%) |
| Mar 2016 | - | $14.30 M(-40.5%) |
| Dec 2015 | $24.02 M(-77.2%) | $24.02 M(-27.6%) |
| Sept 2015 | - | $33.17 M(-43.9%) |
| June 2015 | - | $59.08 M(-37.3%) |
| Mar 2015 | - | $94.16 M(-10.5%) |
| Dec 2014 | $105.26 M(+231.5%) | $105.26 M(-0.2%) |
| Sept 2014 | - | $105.46 M(+398.6%) |
| June 2014 | - | $21.15 M(-33.4%) |
| Dec 2013 | $31.75 M(+171.6%) | $31.75 M |
| Dec 2012 | $11.69 M | - |
FAQ
- What is Eledon Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Eledon Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Eledon Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of ELDN is $4.61 M
What is the all time high annual cash & cash equivalents for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual cash & cash equivalents is $114.19 M
What is Eledon Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, ELDN annual cash & cash equivalents has changed by -$51.80 M (-91.82%)
What is Eledon Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELDN is $6.75 M
What is the all time high quarterly cash and cash equivalents for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly cash and cash equivalents is $114.46 M
What is Eledon Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, ELDN quarterly cash and cash equivalents has changed by +$3.08 M (+84.10%)